LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin-target against Tasmanian Devil Facial Tumor Disease

Published: 08-02-2021| Version 1 | DOI: 10.17632/r93jptbhr2.1
Contributor:
Manuel Alejandro Fernandez-Rojo

Description

This is raw experimental data (western-blots) available for the publication "LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin-target against Tasmanian Devil Facial Tumor Disease."

Files

Steps to reproduce

See STAR PROTOCOLS at the publication "LXR stimulates a metabolic switch and reveals cholesterol homeostasis as a statin-target against Tasmanian Devil Facial Tumor Disease."